Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 24-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg and 801 mg.
Press Release May 24 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release May 11 2022
- Press Release May 04 2022
- Press Release Apr 25 2022
- Press Release Apr 20 2022
- Press Release Apr 12 2022
Later from Alembic Pharmaceuticals
- Press Release Jun 10 2022
- Press Release Jul 29 2022
- Press Release Aug 08 2022
- Press Release Aug 29 2022
- Press Release Oct 27 2022
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals